Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

Like most drugs, Mounjaro can cause side effects. Hair loss was not a reported side effect of Mounjaro, but it was reported with other GLP-1 agonists. Mounjaro can cause side effects, such as ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Recent reports link weight loss drugs Ozempic and Mounjaro to severe vision loss. With cases of blindness emerging, medical ...

There's growing evidence to suggest that GLP-1 drugs, which include Ozempic's semaglutide, may be useful for treating alcohol ...

First we had Oatzempic, the viral drink heralded for its magical weight loss powers. And now TikTokers are raving about a ...